Drug Shortage Report for OXYTOCIN INJECTION, USP

Last updated on 2023-04-05 History
Report ID 160656
Drug Identification Number 02139561
Brand name OXYTOCIN INJECTION, USP
Common or Proper name Oxytocin Injection, USP Synthetic 10 USP units/mL SD Vial 1 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) OXYTOCIN
Strength(s) 10UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1mL
ATC code H01BB
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-05-01
Estimated end date 2023-04-30
Actual end date 2023-04-01
Shortage status Resolved
Updated date 2023-04-05
Company comments On 100% allocation
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-04-05 French Compare
v13 2023-04-05 English Compare
v12 2023-03-01 French Compare
v11 2023-03-01 English Compare
v10 2022-12-07 French Compare
v9 2022-12-07 English Compare
v8 2022-11-02 French Compare
v7 2022-11-02 English Compare
v6 2022-09-26 French Compare
v5 2022-09-26 English Compare
v4 2022-08-19 French Compare
v3 2022-08-19 English Compare
v2 2022-05-15 French Compare
v1 2022-05-15 English Compare

Showing 1 to 14 of 14